Full Text
PDB21 A COST-UTILITY ANALYSIS OF INSULIN GLARGINE (LANTUS) IN THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES

Abstract

Authors

FK Kristensen JM Sverre S Bustad

Back to Volume 6, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×